Table 3.
Diagnostic Value of Individual Parameters in Differentiating Malignant from Nonmalignant Ascites
VEGF, vascular endothelial growth factor; Group 1, malignant ascites of chemonaive patients; Group 2, malignant ascites of chemotreated patients; CEA, carcinoembryonic antigen; CA19 - 9, carbohydrate antigen 19 - 9.
